Related Experiment Videos
[TWAR infection is a common diagnosis in outpatient clinics]
G Falck1, I Engstrand, K Persson
1Oron-, näs-och halsmottagningen, lasarettet, Lindesberg.
Abstract:
Infections caused by Chlamydia pneumoniae were first described in 1985. The infection can cause common cold, sore throat, hoarseness, cough, headache, fatigue and sometimes influenza-like illness. Examination can indicate serous otitis media, sinusitis, laryngitis, bronchitis and pneumonia. The course can be long and relapsing. The recommended drugs for treatment are tetracycline or erythromycin for at least two weeks. Five verified cases are described in the article, four of them with symptoms from the upper respiratory tract only. It is concluded that Chlamydia pneumoniae is a not unusual cause of upper airway diseases. Up to now the diagnosis can best be verified by micro immunofluorescence. The authors call for a rapid and reliable test for use in physician's office. It is proposed that infections caused by Chlamydia pneumoniae be termed TWAR.
Insights
Chlamydia pneumoniae infections, first identified in 1985, commonly cause upper airway illnesses like colds and bronchitis. Diagnosis is best confirmed by micro immunofluorescence, with a need for faster point-of-care testing.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Respiratory Medicine
Background:
- Chlamydia pneumoniae infections were first described in 1985.
- These infections can manifest with symptoms resembling the common cold, sore throat, and influenza-like illness.
Observation:
- Clinical examination may reveal signs of otitis media, sinusitis, laryngitis, bronchitis, and pneumonia.
- The disease course can be prolonged and characterized by relapses.
- Five verified cases were analyzed, with four presenting solely upper respiratory tract symptoms.
Findings:
- Chlamydia pneumoniae is identified as a frequent cause of upper airway diseases.
- Micro immunofluorescence is currently the most reliable diagnostic method.
- Treatment typically involves tetracycline or erythromycin for a minimum of two weeks.
Implications:
- The study highlights the significance of Chlamydia pneumoniae in respiratory infections.
- There is a pressing need for rapid, reliable diagnostic tests suitable for clinical settings.
- The authors propose standardizing the nomenclature for these infections as TWAR (The Wuhan-1 Associated Respiratory agent).